In ovarian cancer cells, c-Myb plays a crucial role in promoting NF-κB signaling, which in turn contributes to cancer growth, invasion, and resistance to cisplatin chemotherapy (Tian et al., 2019). Here, NFKB1 is linked to ovarian carcinoma.